Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 8, 13 November 2023
Open
Access | Article
Comparison between the private healthcare system and the universal healthcare system in the U.S.
* Author to whom correspondence should be addressed.
Abstract
The United States is one of the most developed countries in the world, but unlike most other developed countries, it does not have a universal healthcare system that provides easy and equal access for all people and communities regardless of ethnic and socioeconomic status. The private healthcare system in the United States not only drives higher costs of illness but also provides a lower quality of services than those of the universal healthcare systems. This paper compares the private healthcare system in the United States to the universal healthcare system from three perspectives: hospitalization, health insurance, and administration cost. And it finds that since the healthcare industry has higher entry barriers than most other industries, industrial monopolization appears as new businesses could not enter the industry easily, which leads to a high cost of illness. Also, the quality of services in the private healthcare system may not be guaranteed due to the lack of government direct control of fund distribution, service quality, and horizontal integrations. Furthermore, the new healthcare technology may also benefit from the universal healthcare system as a result of better resource allocation. This study indicates that the universal healthcare system may benefit care access and population health.
Keywords
Hospitalization, Complex Healthcare Structure, Health Insurance, Administration Costs
References
1. Morgan, K. The Welfare State Nobody Knows: Debunking Myths about U.S. Social Policy and Welfare Discipline: Discourse, Governance, and Globalization. Perspectives on Politics, 6(1), 177-178 (2008). doi:10.1017/S1537592708080274
2. Vladeck B. Universal health insurance in the United States: reflections on the past, the present, and the future. Am J Public Health. Jan;93(1):16-9 (2003). doi: 10.2105/ajph.93.1.16. PMID: 12511377; PMCID: PMC1447684.
3. Eric C. Schneider et al., (2021) Mirror, Mirror 2021 — Reflecting Poorly: Health Care in the U.S. Compared to Other High-Income Countries, Commonwealth Fund, Aug. https://doi.org/10.26099/01DV-H208
4. Vita MG, Sacher S. The Competitive Effects of Not-For-Profit Hospital Mergers: a Case Study. Journal of Industrial Economics, vol. 49, no. 1 (2001).
5. Lipsitz LA. Understanding health care as a complex system: the foundation for unintended consequences. JAMA. Jul 18;308(3):243-4 (2012). doi: 10.1001/jama.2012.7551. PMID: 22797640; PMCID: PMC3511782.
6. Largest health insurance companies of 2023. value penguin. (n.d.). https://www.valuepenguin.com/largest-health-insurance-companies
7. Andreja Detiček, Igor Locatelli, Mitja Kos, Patient Access to Medicines for Rare Diseases in European Countries, Value in Health, Volume 21, Issue 5, pp.553-560 (2018), https://doi.org/10.1016/j.jval.2018.01.007.
8. James D. Chambers, PhD, Ari D. Panzer, BS, David D. Kim, PhD, Nikoletta M. Margaretos, BA, Peter J. Neumann, ScD, Variation in US Private Health Plans’ Coverage of Orphan Drugs, The American Journal of Managed Care, October, Volume 25, Issue 10 (2019). https://www.ajmc.com/view/variation-in-us-private-health-plans-coverage-of-orphan-drugs
9. Gammie, T., Lu, C. Y., & Ud-Din Babar, Z. Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries. PLoS ONE, 10(10) (2014). https://doi.org/10.1371/journal.pone.0140002
10. Bloom DE, Khoury A, Subbaraman R. The promise and peril of universal health care. Science. 2018 Aug 24;361(6404):eaat9644. doi: 10.1126/science.aat9644. PMID: 30139847; PMCID: PMC6510304.
11. Industry market research, reports, and Statistics. IBISWorld. (n.d.). https://www.ibisworld.com/industry-statistics/employment/health-medical-insurance-united-states/#:~:text=There%20are%20563%2C366%20people%20employed,the%20US%20as%20of%202023.
12. Health Insurance Ceo Salary | comparably. https://www.comparably.com/salaries/salaries-for-ceo
13. Woolhandler, S., Campbell, T. M., & Himmelstein, D. U. (n.d.). Costs of Health Care Administration in the United States and Canada. The new England journal of medicine. https://www.nejm.org/doi/full/10.1056/NEJMsa022033
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-111-7
- ISBN (Online)
- 978-1-83558-112-4
- Published Date
- 13 November 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/8/20240358
- Copyright
- 13 November 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited